LCN2 and Sepsis: LCN2 has been proven to differentially expressed between septic shock and sepsis in surgical patients (Martin-Fernandez et al., 2020), and has been reported as a potential biomarker of septic-shock-associated acute kidney injury (Tang et al., 2021).